I read the report and there is no mention.
There is a page on the site that refers to the phaseIII protocal and talks about having 10 sites and over 250 patients. But that is the old protocal. Is this what you are referencing? Because that is old data. I also wondered why they didn't update that.
The pivotal phase III trial (with doxo.) is well underway. The company had announced the first patient enrolments a couple of months ago and they have apparently indicated somewhere that they will not put out releases every time a new patient is enrolled.
There is a phase 2 with melphalan that has not yet started.